Literature DB >> 22506622

Involvement of lymphocyte infiltration in the progression of mouse peritoneal fibrosis model.

Tomoya Nishino1, Ryuichi Ashida, Yoko Obata, Akira Furusu, Katsushige Abe, Masanobu Miyazaki, Takehiko Koji, Shigeru Kohno.   

Abstract

Peritoneal fibrosis is a serious complication in patients with severe chronic kidney disease who are undergoing peritoneal dialysis (PD). One of the pathological characteristics of peritoneal fibrosis is the infiltration of macrophages in the thickened submesothelial compact zone. In addition, infiltration of lymphocytes, including T and B lymphocytes, is observed in the fibrotic peritoneum. However, the relationship between lymphocyte infiltration and progression of peritoneal fibrosis remains unclear. In this study, we investigated the role of lymphocytes in the development of peritoneal fibrosis induced by chlorhexidine gluconate (CG) by comparing the histological changes observed in severe combined immunodeficient (SCID) mice (largely lacking functional T and B lymphocytes) with those observed in wild-type (WT) mice. As expected, CG-injected WT mice showed a thickening of the submesothelial compact zone together with massive collagen deposition accompanied by increased numbers of infiltrating macrophages and T and B lymphocytes. In the peritoneum of SCID mice, the submesothelial compact zone was thicker and the number of macrophages and B lymphocytes was significantly higher than that observed in control immunodeficient and WT mice. In contrast, the number of T lymphocytes in the peritoneum of SCID mice was significantly lower than that in the peritoneum of WT mice. These results suggest that T and B lymphocytes modulate the process of peritoneal fibrosis via macrophage infiltration.

Entities:  

Mesh:

Year:  2012        PMID: 22506622     DOI: 10.3109/0886022X.2012.676527

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  4 in total

1.  Suramin inhibits the development and progression of peritoneal fibrosis.

Authors:  Chongxiang Xiong; Na Liu; Lu Fang; Shougang Zhuang; Haidong Yan
Journal:  J Pharmacol Exp Ther       Date:  2014-08-28       Impact factor: 4.030

2.  New insights into therapeutic strategies for the treatment of peritoneal fibrosis: learning from histochemical analyses of animal models.

Authors:  Mineaki Kitamura; Tomoya Nishino; Yoko Obata; Yoshiyuki Ozono; Takehiko Koji; Shigeru Kohno
Journal:  Acta Histochem Cytochem       Date:  2014-07-16       Impact factor: 1.938

3.  Novel Application of Magnetite Nanoparticle-Mediated Vitamin D3 Delivery for Peritoneal Dialysis-Related Peritoneal Damage.

Authors:  Fong-Yu Cheng; Yuan-Yow Chiou; Shih-Yuan Hung; Tsun-Mei Lin; Hao-Kuang Wang; Chi-Wei Lin; Hung-Hsiang Liou; Min-Yu Chang; Hsi-Hao Wang; Yi-Che Lee
Journal:  Int J Nanomedicine       Date:  2021-03-11

4.  The effect of rituximab on encapsulated peritoneal sclerosis in an experimental rat model

Authors:  Süleyman Karaköse; Ayşe Zeynep Bal; Eylem Pinar Eser; Murat Duranay
Journal:  Turk J Med Sci       Date:  2020-06-23       Impact factor: 0.973

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.